Catalyst Wire Dossier Catalyst Wire Dossier

Mezigdomide

mezigdomide
Drug timelines are a Plus or Pro feature.

15 regulatory and trial events tracked for Mezigdomide, covering 2024-11-19 to 2026-04-21. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Evaluate Alnuctamab in Combination With Mezigdomide in Participants With Relapsed and/or Refractory Multiple Myeloma [Phase 1]

See pricing